Cytrans Elashield
FDA 510(k) K253317 · GC America, Inc.
510(k) numberK253317
Submission
- Device name
- Cytrans Elashield
- Applicant
- GC America, Inc.
Alsip, IL, US - Received
- September 30, 2025
- Decision date
- July 6, 2026
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- LYC – Bone Grafting Material, Synthetic
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 872.3930
- Specialty
- Dental
- Implant
- Yes
A synthetic bone grafting material is synthetically-derived device, such as hydroxylapatite, intended to fill, augment, or reconstruct periodontal and or bony defects of the upper or lower jaw.
Other 510(k)s with product code LYC
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K253883 | Bonalive MaxillofacialLYC · Special | Bonalive , Ltd. | 05/14/2026SE |
| K251818 | Bontree PlusLYC · Traditional | Hudens Bio Co., Ltd. | 03/06/2026SE |
| K244006 | FG Bone Graft MLYC · Traditional | Full Golden Biotech Co., Ltd. | 09/17/2025SE |
| K243745 | FG Bone Graft BLYC · Traditional | Full Golden Biotech Corporation | 08/29/2025SE |
| K241186 | Synthetic Bone Graft ParticulateLYC · Traditional | Shenzhen Dazhou Medical Technology Co., Ltd. | 02/21/2025SE |
| K213260 | CMFlexTMLYC · Traditional | Dimension Inx Corp. | 12/30/2022SE |
| K202675 | InRoad® Dental Synthetic Bone GraftLYC · Traditional | Osteogene Tech Corp | 03/04/2022SE |
| K201546 | OsOpia Synthetic Bone Void FillerLYC · Traditional | Revisios BV | 10/02/2020SE |
| K201051 | Straumann BoneCeramicLYC · Traditional | Institut Straumann AG | 09/24/2020SE |
| K192597 | Cytrans GranulesLYC · Abbreviated | GC America, Inc. | 08/17/2020SE |
More from GC America, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K262202 | Cerasmart ForteEBF · Traditional | 09/10/2026SE |
| K261246 | SRGC-06EBF · Traditional | 06/18/2026SE |
| K254109 | G-Cem UniversalEMA · Traditional | 05/18/2026SE |
| K251124 | G-Bond UniversalKLE · Traditional | 10/02/2025SE |
| K250953 | Equia LC OneEMA · Traditional | 09/19/2025SE |
| K251946 | G aenial Universal Injectable IIEBF · Traditional | 08/29/2025SE |
| K200798 | G-Cem OneEMA · Traditional | 11/24/2020SE |
| K200682 | BZF-29KLE · Traditional | 10/02/2020SE |
| K192597 | Cytrans GranulesLYC · Abbreviated | 08/17/2020SE |
| K193113 | GC Temp PrintEBG · Traditional | 07/09/2020SE |
Questions and answers
When was Cytrans Elashield cleared by the FDA?
Cytrans Elashield (K253317) received a 510(k) decision of Substantially Equivalent on July 6, 2026, 279 days after the submission was received.
What is the product code of K253317?
The FDA product code is LYC – Bone Grafting Material, Synthetic, a Class II (moderate risk) device regulated under 21 CFR 872.3930.